Search Results - "Fonteneau, Jean‐François"

Refine Results
  1. 1

    Endogenous retrovirus expression activates type-I interferon signaling in an experimental mouse model of mesothelioma development by Sun, Suna, Frontini, Francesca, Qi, Weihong, Hariharan, Ananya, Ronner, Manuel, Wipplinger, Martin, Blanquart, Christophe, Rehrauer, Hubert, Fonteneau, Jean-François, Felley-Bosco, Emanuela

    Published in Cancer letters (01-06-2021)
    “…Early events in an experimental model of mesothelioma development include increased levels of editing in double-stranded RNA (dsRNA). We hypothesised that…”
    Get full text
    Journal Article
  2. 2

    Measles Virus Vaccine―Infected Tumor Cells Induce Tumor Antigen Cross-Presentation by Human Plasmacytoid Dendritic Cells by GUILLERME, Jean-Baptiste, BOISGERAULT, Nicolas, ROULOIS, David, MENAGER, Jérémie, COMBREDET, Chantal, TANGY, Frédéric, FONTENEAU, Jean-François, GREGOIRE, Marc

    Published in Clinical cancer research (01-03-2013)
    “…Plasmacytoid dendritic cells (pDC) are antigen-presenting cells specialized in antiviral response. The measles virus vaccine is proposed as an antitumor agent…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Human Immunodeficiency Virus Type 1 Activates Plasmacytoid Dendritic Cells and Concomitantly Induces the Bystander Maturation of Myeloid Dendritic Cells by FONTENEAU, Jean-Francois, LARSSON, Marie, BEIGNON, Anne-Sophie, MCKENNA, Kelli, DASILVA, Ida, AMARA, Ali, LIU, Yong-Jun, LIFSON, Jeffrey D, LITTMAN, Dan R, BHARDWAJ, Nina

    Published in Journal of Virology (01-05-2004)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  6. 6

    Homozygous Co-Deletion of Type I Interferons and CDKN2A Genes in Thoracic Cancers: Potential Consequences for Therapy by Grard, Marion, Chatelain, Camille, Delaunay, Tiphaine, Pons-Tostivint, Elvire, Bennouna, Jaafar, Fonteneau, Jean-François

    Published in Frontiers in oncology (24-06-2021)
    “…Homozygous deletion (HD) of the tumor suppressor gene CDKN2A is the most frequent genetic alteration in malignant pleural mesothelioma and is also frequent in…”
    Get full text
    Journal Article
  7. 7

    The DCMU Herbicide Shapes T-cell Functions By Modulating Micro-RNA Expression Profiles by Autin, Pierre, Deshayes, Sophie, Lea, Juliette, Boisgerault, Nicolas, Dupré, Emilie, Labarrière, Nathalie, Leguevel, Rémy, Fonteneau, Jean-François, Blanquart, Christophe, Fradin, Delphine

    Published in Frontiers in immunology (28-07-2022)
    “…DCMU [N-(3,4-dichlorophenyl)-N-dimethylurea] or diuron is a widely used herbicide, which can cause adverse effects on human, especially on immune cells, due to…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Activation of influenza virus–specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity by Fonteneau, Jean-François, Gilliet, Michel, Larsson, Marie, Dasilva, Ida, Münz, Christian, Liu, Yong-Jun, Bhardwaj, Nina

    Published in Blood (01-05-2003)
    “…Plasmacytoid dendritic cells (pDCs) contribute to innate antiviral immune responses by producing type I interferons (IFNs) upon exposure to enveloped viruses…”
    Get full text
    Journal Article
  10. 10

    A Functional Assay to Determine the Capacity of Oncolytic Viruses to Induce Immunogenic Tumor Cell Death by Delaunay, Tiphaine, Achard, Carole, Grégoire, Marc, Tangy, Frédéric, Boisgerault, Nicolas, Fonteneau, Jean-François

    “…Oncolytic immunotherapy efficacy relies partially on the induction of immunogenic tumor cell death following infection with oncolytic viruses (OV) to induce an…”
    Get more information
    Journal Article
  11. 11

    MUC1-Specific Cytotoxic T Lymphocytes in Cancer Therapy: Induction and Challenge by Roulois, David, Fonteneau, Jean-François, Grégoire, Marc

    Published in BioMed research international (01-01-2013)
    “…MUC1 glycoprotein is often found overexpressed and hypoglycosylated in tumor cells from numerous cancer types. Since its discovery MUC1 has been an attractive…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Viral cancer therapies: are they ready for combination with other immunotherapies? by Boisgerault, Nicolas, Grégoire, Marc, Fonteneau, Jean-François

    Published in Future oncology (London, England) (01-08-2017)
    “…Due to their ability to specifically target and kill cancer cells without replicating in the healthy ones, they have been extensively studied over the last two…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Downregulation of MUC1 expression and its recognition by CD8+ T cells on the surface of malignant pleural mesothelioma cells treated with HDACi by Roulois, David, Blanquart, Christophe, Panterne, Clarisse, Gueugnon, Fabien, Grégoire, Marc, Fonteneau, JeanFrançois

    Published in European journal of immunology (01-03-2012)
    “…Research into new treatments against malignant pleural mesothelioma (MPM) is of great interest, as this aggressive cancer is often resistant to conventional…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Viral Mimicry Response Is Associated With Clinical Outcome in Pleural Mesothelioma by Sun, Suna, Qi, Weihong, Rehrauer, Hubert, Ronner, Manuel, Hariharan, Ananya, Wipplinger, Martin, Meiller, Clément, Stahel, Rolf, Früh, Martin, Cerciello, Ferdinando, Fonteneau, Jean-François, Jean, Didier, Felley-Bosco, Emanuela

    Published in JTO clinical and research reports (01-12-2022)
    “…The aim of this study was to investigate endogenous retrovirus (ERV) expression and type I interferon (IFN) activation in human pleural mesothelioma (PM) and…”
    Get full text
    Journal Article